US Patent Issued to NAVICURE BIOPHARMACEUTICALS on July 15 for "Fusion proteins for immunotherapy against cancer and infectious diseases" (Taiwanese Inventor)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,996, issued on July 15, was assigned to NAVICURE BIOPHARMACEUTICALS Ltd. (Apia, Samoa).

"Fusion proteins for immunotherapy against cancer and infectious diseases" was invented by Chia-Mao Wu (Hsinchu, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Fusion proteins for immunotherapy against cancer and infectious diseases are disclosed. A fusion protein according to the invention comprises a CD40-binding domain; an antigen; and a translocation domain located between the CD40-binding domain and the antigen, in which a furin and/or cathepsin L cleavage site is present in the fusion protein between the CD40-binding domain and the translocation doma...